What's breaking now, across thousands of outlets.
(RTTNews) - Pharming Group N.V. (PHARM.AS) said the U.S. Food and Drug Administration has approved Joenja (leniolisib) for children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome, or APDS, who weigh at least 27 kg.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
(MedPage Today) -- President Donald Trump, Vice President JD Vance, and other Republican officials came together for a 2-day convention this week to rally voters in advance of the midterm elections in…
(MedPage Today) -- Members of the American Diabetes Association (ADA) have launched a boycott against the organization, condemning leadership's actions in the aftermath of five researchers being…
“The wider Middle East conflict has impacted two major ocean shipping waterways – the Red Sea and the Strait of Hormuz. They have both been compromised due to the geopolitical situation in the Middle…
Every Scan. One Plan. One Platform. With Medicare coverage now finalized for asymptomatic severe aortic stenosis, cvi42 gives TAVR programs the automated planning, standardized reporting, and…
